Merck & Co as of June 30, 2025
Portfolio Holdings for Merck & Co
Merck & Co holds 13 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Personalis Ord (PSNL) | 42.7 | $92M | 14M | 6.56 | |
| Moderna (MRNA) | 29.5 | $64M | 2.3M | 27.59 | |
| Kymera Therapeutics (KYMR) | 15.6 | $34M | 772k | 43.64 | |
| Entrada Therapeutics | 5.4 | $12M | 1.7M | 6.72 | |
| Alector (ALEC) | 2.3 | $5.0M | 3.5M | 1.40 | |
| Evaxion Biotech A/s Sponsored Ads | 1.4 | $3.0M | 1.2M | 2.45 | |
| Sutro Biopharma (STRO) | 0.9 | $1.9M | 2.7M | 0.71 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.7 | $1.5M | 1.1M | 1.32 | |
| Miragen Therapeutics (VRDN) | 0.6 | $1.3M | 93k | 13.98 | |
| Xilio Therapeutics (XLO) | 0.5 | $1.0M | 1.5M | 0.68 | |
| Carisma Therapeutics (CARM) | 0.3 | $577k | 1.5M | 0.39 | |
| Neuphoria Therapeutics (NEUP) | 0.0 | $71k | 10k | 7.10 | |
| Tuhura Biosciences (HURA) | 0.0 | $31k | 14k | 2.23 |
